People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Edgemont Pharmaceuticals, LLC | — | Pharmaceuticals | Series A | $6.2M | $150.1M | 2010 |
Christine A. Blumhardt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christine A. Blumhardt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert A Zerbe | 1 | 2 |
| Timothy A. McInerney | 1 | 1 |
| Barbara A. Duncan | 1 | 1 |
| Douglas A. Saltel | 1 | 1 |
| Mike A. Vachon | 1 | 1 |
| Warren A. Stern | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.